STAT

MARCH 28, 2024

Our colleague Sarah Owermohle joins us to explain the Supreme Court case that could have dramatic effects on access to medication abortion — and the development of new medicines. We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

230

230

STAT

MARCH 15, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send  Don’t be shy.

213

213

STAT

MARCH 29, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

195

195

STAT

MARCH 14, 2024

Bioethicist Holly Fernandez Lynch joins us to discuss the case of Amylyx Pharmaceuticals’ treatment for ALS and what its failure means for drug development. We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

Drug Development 240

Drug Development 240

STAT

APRIL 5, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

186

186

STAT

JANUARY 8, 2024

It’s the time of year when we’re most susceptible to such messaging: Surveys show that at least one-third of our New Year’s resolutions focus on exercising, losing weight, or eating better. The marketing campaigns work: Each January, fitness app downloads spike 36% higher than usual.

355

355

STAT

APRIL 12, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

165

165

STAT

MARCH 8, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

197

197

STAT

JANUARY 26, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send  Don’t be shy.

222

222

STAT

JANUARY 5, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send

216

216

STAT

MAY 9, 2024

As for us, we are engaged in the usual ritual of brewing cups of stimulation. As always, you are invited to join us. … Pfizer agreed to settle more than 10,000 cases accusing it of hiding cancer risks of its Zantac heartburn drug, Bloomberg News reports. Our choice today is orange cream.

203

203

STAT

FEBRUARY 9, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send  Don’t be shy.

196

196

STAT

FEBRUARY 23, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

186

186

STAT

MAY 6, 2024

Steward Health Care, which once trumpeted its community hospital system as a low-cost alternative to Boston’s medical goliaths before expanding nationally and falling into a deep financial crisis, filed for bankruptcy protection early Monday morning.

Hospitals 178

Hospitals 178

STAT

DECEMBER 8, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.    Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

221

221

STAT

SEPTEMBER 14, 2023

Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

278

278

STAT

FEBRUARY 2, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send  Don’t be shy.

180

180

STAT

NOVEMBER 2, 2023

Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin. We also discuss the latest news in the life sciences, including the future of Sarepta and the retirement of a biotech stalwart. Read the rest…

225

225

STAT

DECEMBER 1, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.     Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right.  Don’t be shy.

205

205

STAT

OCTOBER 20, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

228

228

STAT

FEBRUARY 16, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others. That’s  Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

161

161

STAT

JANUARY 12, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send

179

179

STAT

APRIL 4, 2024

Oruka Therapeutics CEO Lawrence Klein joins us to discuss how his company raised its first round of financing before competing with major players in the inflammation space. We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

Vaccines 153

Vaccines 153

STAT

OCTOBER 26, 2023

Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

226

226

STAT

JUNE 22, 2023

Our colleague Bob Herman joins us to explain his year-long investigation into some brazen conflicts of interest in the world of prescription drug pricing. Then, STAT’s Helen Branswell calls in to walk us through a news-packed week for vaccines, including weighty decisions for Covid-19 and RSV. Read the rest…

Vaccines 206

Vaccines Drug Pricing 206

STAT

MARCH 7, 2024

STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

184

184

STAT

FEBRUARY 15, 2024

STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices.

Drug Pricing 198

Drug Pricing 198

STAT

JANUARY 19, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others.    Send us your changes, and we’ll find a home for them. Don’t Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send  Don’t be shy.

168

168

STAT

OCTOBER 27, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

202

202

STAT

DECEMBER 15, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send

182

182

STAT

SEPTEMBER 22, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.    Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

213

213

STAT

SEPTEMBER 15, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them.  Don’t Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send

219

219

STAT

NOVEMBER 3, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  That’s  Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

176

176

STAT

JULY 20, 2023

What can Homer teach us about biotech? Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

192

192

pharmaphorum

APRIL 2, 2024

Acorda Therapeutics has filed for bankruptcy protection, hoping to keep operating while it tries to arrange the sale of its main assets to a US subsidiary of Germany’s Merz. The announcement made last night US time sparked a run on Acorda's shares, down almost 62% at the time of writing.

109

109

STAT

SEPTEMBER 1, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others. That’s  Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

193

193

STAT

AUGUST 18, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.    Send us your changes, and we’ll find a home for them. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

178

178